Guangzhou Baiyunshan Pharmaceutical Holdings and its subsidiaries are engaged in the manufacture and sales of Chinese Patent Medicine ("CPM"); wholesale, retail, import and export of western and Chinese pharmaceutical products, CPM, Chinese raw medicine and medical apparatus; research and development of natural medicine and biological medicine; and processing of health care beverages and drinks. Co.'s major products include diabetes medicine, heat clearing and anti-toxic medicine, cough and phlegm clearing medicine, arthritis medicine and gastric medicine. Through its associates, Co., is also engaged in the managing of fund and producing of health medicine.
theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.